BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,408,000 | -38.6% | 200,000 | -27.3% | 0.46% | -31.4% |
| Q1 2023 | $2,294,000 | -11.2% | 275,000 | +22.2% | 0.68% | -38.5% |
| Q4 2022 | $2,583,000 | -61.0% | 225,000 | -57.1% | 1.10% | -40.6% |
| Q3 2022 | $6,615,000 | +92.4% | 525,000 | +61.5% | 1.86% | +3.7% |
| Q2 2022 | $3,439,000 | -39.6% | 325,000 | -7.1% | 1.79% | +45.0% |
| Q1 2022 | $5,691,000 | +11.9% | 350,000 | -30.0% | 1.24% | +3.3% |
| Q1 2021 | $5,085,000 | -24.2% | 500,000 | -44.4% | 1.20% | -20.0% |
| Q4 2020 | $6,705,000 | +0.1% | 900,000 | -53.8% | 1.49% | -22.8% |
| Q3 2020 | $6,698,000 | -26.0% | 1,950,000 | +2.6% | 1.94% | -19.0% |
| Q2 2020 | $9,054,000 | +126.4% | 1,900,000 | -5.0% | 2.39% | +125.2% |
| Q1 2020 | $4,000,000 | -61.4% | 2,000,000 | -33.3% | 1.06% | -46.2% |
| Q4 2019 | $10,350,000 | +140.8% | 3,000,000 | +100.0% | 1.97% | +80.0% |
| Q3 2019 | $4,298,000 | -54.6% | 1,500,000 | -40.0% | 1.10% | -44.3% |
| Q2 2019 | $9,475,000 | +132.8% | 2,500,000 | +400.0% | 1.96% | +84.9% |
| Q1 2019 | $4,070,000 | +0.9% | 500,000 | 0.0% | 1.06% | -27.4% |
| Q4 2018 | $4,035,000 | +5.8% | 500,000 | 0.0% | 1.46% | +80.5% |
| Q3 2018 | $3,815,000 | +45.6% | 500,000 | 0.0% | 0.81% | +45.9% |
| Q3 2017 | $2,620,000 | -30.2% | 500,000 | -25.9% | 0.56% | -28.7% |
| Q2 2017 | $3,753,000 | -70.2% | 675,000 | -55.0% | 0.78% | -66.8% |
| Q1 2017 | $12,600,000 | +73.1% | 1,500,000 | +30.4% | 2.35% | +34.0% |
| Q4 2016 | $7,280,000 | -8.3% | 1,150,000 | -36.1% | 1.75% | +36.1% |
| Q3 2016 | $7,938,000 | +64.4% | 1,800,000 | +5.9% | 1.29% | -7.7% |
| Q2 2016 | $4,828,000 | +88.2% | 1,700,000 | +655.6% | 1.39% | +20.8% |
| Q3 2015 | $2,565,000 | +281.7% | 225,000 | +400.0% | 1.15% | +429.4% |
| Q2 2015 | $672,000 | – | 45,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |